Need Help?

CLUSTER RNAseq Study of Juvenile Idiopathic Arthritis patients in methotrexate cohort

CLUSTER aims to discover novel disease mechanisms and biomarkers in children suffering from Juvenile idiopathic arthritis (JIA). Currently, little is known about the pathological disease mechanisms of JIA and there are no validated tools capable of predicting response or non-response to treatment. The study aims to identify biomarkers for treatment response using RNAseq technology. The samples used in this study comes from blood samples that were collected prior to patients receiving methotrexate treatment (naive). These samples were then processed for PBMC isolation followed by sorting cells into 4 different immune cell types. All of these samples were then sequenced by NovaSeq6000.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000001455 Illumina NovaSeq 6000 416
EGAD50000001456 Illumina NovaSeq 6000 416
EGAD50000001457 Illumina NovaSeq 6000 416
EGAD50000001458 Illumina NovaSeq 6000 416
EGAD50000001459 Illumina NovaSeq 6000 416
Publications Citations
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis.
Ann Rheum Dis 84: 2025 1412-1424
1